Dr. Anil K. PATRI will explain FDA’s vision on nanomaterials for medecine, currently and in the future, including regulation & toxicity aspects. The conference will be held on September 6th at the Institut de Physique et de Chimie des Matériaux de Strasbourg (IPCMS) from 10.00 to 12.00 and is open and free of charge.

This event is a great opportunity for the NANOTRANSMED consortium, for discussing with Dr. Anil PATRI about future authorizations of clinical testing for the dendronised nano-objects developed in the project and also about possibilities of technology transfer towards the industry.

NANOTRANSMED is a European project, led by a french-german-swiss consortium and cofinanced by the INTERREG VA Upper Rhine Programme. NANOTRANSMED enables French, German and Swiss scientists to develop together applications and innovations in nanomedicine.

www.nanotransmed.eu